Transplantation And Cellular Therapy SCIE

国际简称：BIOL BLOOD MARROW TR 参考译名：移植和细胞治疗

主要研究方向：Medicine-Hematology 非预警期刊审稿周期：

《移植和细胞治疗》(Transplantation And Cellular Therapy)是一本由Elsevier出版的以Medicine-Hematology为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q1 JCR分区
295 年发文量
3.6 IF影响因子
开放是否OA
None 出版语言

Transplantation and Cellular Therapy, the official publication of the American Society for Transplantation and Cellular Therapy , focuses on current technology and knowledge in the interdisciplinary field of hematopoetic stem cell transplantation and the growing field of transplant and non-transplant cellular immunotherapies. The Journal publishes original research reports, practice guidelines, reviews, editorials, commentaries, and letters to the editor.This magazine is committed to promoting the development of scientific research and clinical applications in the fields of cell therapy and transplantation, providing a platform for scientists, doctors, and researchers engaged in related research worldwide to exchange and share the latest research results. As a professional journal focusing on the fields of cell therapy and transplantation, it provides a platform for researchers to showcase their research results and exchange academic views, which is of great significance for promoting the development of related fields.

[ 查看全部 ]

投稿咨询加急咨询

Transplantation And Cellular Therapy期刊信息

ISSN：2666-6375
出版语言：None
是否OA：开放
E-ISSN：2666-6367
出版地区：UNITED STATES
是否预警：否
出版商：Elsevier
开源占比：0.1987
Gold OA文章占比：76.35%
OA被引用占比：
出版国人文章占比：0
出版撤稿占比：
研究类文章占比：94.58%

Transplantation And Cellular Therapy CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

1.602

1.113

学科类别	分区	排名	百分位
大类：Medicine 小类：Transplantation	Q1	11 / 54	80%
大类：Medicine 小类：Hematology	Q1	30 / 137	78%
大类：Medicine 小类：Immunology and Allergy	Q2	82 / 233	65%
大类：Medicine 小类：Molecular Medicine	Q2	66 / 178	63%
大类：Medicine 小类：Cell Biology	Q2	128 / 285	55%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Transplantation And Cellular Therapy中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 TRANSPLANTATION 移植	3区 3区 3区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	HEMATOLOGY 血液学 TRANSPLANTATION 移植 IMMUNOLOGY 免疫学	2区 2区 3区

Transplantation And Cellular Therapy JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：HEMATOLOGY	SCIE	Q2	25 / 97	74.7%
学科：IMMUNOLOGY	SCIE	Q2	86 / 181	52.8%
学科：TRANSPLANTATION	SCIE	Q1	7 / 31	79%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：HEMATOLOGY	SCIE	Q1	24 / 97	75.77%
学科：IMMUNOLOGY	SCIE	Q2	48 / 181	73.76%
学科：TRANSPLANTATION	SCIE	Q2	8 / 31	75.81%

Transplantation And Cellular Therapy历年数据统计

影响因子

中科院分区

Transplantation And Cellular Therapy中国学者发文选摘

1、Alternative Transplantation With Post-Transplantation Cyclophosphamide in Aplastic Anemia: A Retrospective Report From the BMF-WG of Hunan Province, China
Author: Gong, Susu; Chen, Cong; Chen, Keke; Yang, Rui; Wang, Leyuan; Yang, Kaitai; Hu, Jian; Nie, Lin; Su, Tao; Xu, Yajing; He, Xianglin; Yang, Liangchun; Xiao, Hong; Fu, Bin

Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 1, pp. 480-480000000. DOI: 10.1016/j.jtct.2022.10.006
2、Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients
Author: Deng, Rui-Xin; Zhu, Xiao-Lu; Zhang, Ao-Bei; He, Yun; Fu, Hai-Xia; Wang, Feng-Rong; Mo, Xiao-Dong; Wang, Yu; Han, Wei; Chen, Huan; Chen, Yao; Yan, Chen-Hua; Wang, Jing-Zhi; Han, Ting -Ting; Chen, Yu -Hong; Chang, Ying-Jun; Xu, Lan -Ping; Huang, Xiao-Jun; Zhang, Xiao-Hui

Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 1, pp. 570-570000000000. DOI: 10.1016/j.jtct.2022.10.007
3、Characteristics of Engraftment Syndrome following Autologous Stem Cell Transplantation in Light Chain Amyloidosis with Renal Involvement
Author: Miao, Fujia; Ren, Guisheng; Guo, Jinzhou; Zhao, Liang; Xu, Weiwei; Huang, Xianghua

Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 2, pp. 1100-11000000000. DOI: 10.1016/j.jtct.2022.10.021
4、Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Hematologic Malignancy
Author: Li, Zhihui; An, Na; Yang, Keyan; Meng, Fanqiao; Xu, Teng; Peng, Xiaojuan; Wen, Xiaopei; Li, Jing; Song, Yanzhi; Yang, Rui; Wu, Tong

Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 3, pp. 167-173. DOI: 10.1016/j.jtct.2022.11.013
5、A Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Author: Zhang, Ao-Bei; Wang, Chen-Cong; Zhao, Peng; Tong, Ke-Ting; He, Yun; Zhu, Xiao-Lu; Fu, Hai-Xia; Wang, Feng-Rong; Mo, Xiao-Dong; Wang, Yu; Zhao, Xiang-Yu; Zhang, Yuan-Yuan; Han, Wei; Chen, Huan; Chen, Yao; Yan, Chen-Hua; Wang, Jing-Zhi; Han, Ting-Ting; Sun, Yu-Qian; Chen, Yu-Hong; Chang, Ying-Jun; Xu, Lan-Ping; Liu, Kai-Yan; Huang, Xiao-Jun; Zhang, Xiao-Hui

Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 4, pp. -. DOI: 10.1016/j.jtct.2022.12.008